A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPG

Clinical trial NCT03330197 · TERMINATED

Trial details

NCT number: NCT03330197
Sponsor: Alaunos Therapeutics
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pediatric Brain Tumor Diffuse Intrinsic Pontine Glioma

Start date: 2017-09-26
Primary completion: 2021-09-10
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.